Aquilon Pharma Overview

  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series B
  • (In Progress)
  • Investors
  • 5

Aquilon Pharma General Information

Description

Operator of a pharmaceutical firm intended to develop drugs for the treatment of pulmonary diseases. The company's firm focuses on the development of drugs for the treatment of respiratory disorders and enhances both the lung deposition and the pharmacology of existing drugs for asthma and chronic obstructive pulmonary disease (COPD), enabling patients to get efficient inhalation drugs for respiratory problems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Pending Transaction (VC)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 52 Quai De La Boverie
  • Walloon Region
  • 4020 Liege
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aquilon Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 00.000 In Progress Generating Revenue
3. Early Stage VC 12-Dec-2018 00.00 00.000 Completed Generating Revenue
2. Angel (individual) 26-Oct-2015 $388K $388K 00000 Completed Generating Revenue
1. Accelerator/Incubator 14-Nov-2011 Completed Generating Revenue
To view Aquilon Pharma’s complete valuation and funding history, request access »

Aquilon Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 00000.00 00000.00 00 00000.00 00.000
To view Aquilon Pharma’s complete cap table history, request access »

Aquilon Pharma Executive Team (7)

Name Title Board Seat Contact Info
Paul Maes Chief Executive Officer & Chairman
Pascal Alexis Chief Financial Officer & Executive, Financial Operations
Ludivine Petit Chief Operating Officer
Brigitte Evrard Co-Founder
Frank Pieters Board Member & Chairman, Strategic Committee
You’re viewing 5 of 7 executive team members. Get the full list »

Aquilon Pharma Board Members (3)

Name Representing Role Since
Didier Cataldo Aquilon Pharma Chairman, Scientific Committee 000 0000
Frank Pieters Aquilon Pharma Board Member & Chairman, Strategic Committee 000 0000
Paul Maes Aquilon Pharma Chief Executive Officer & Chairman 000 0000
To view Aquilon Pharma’s complete board members history, request access »

Aquilon Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aquilon Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Noshaq Venture Capital Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
Scale Investment Funds Venture Capital Minority 000 0000 000000 0
Be Angels Angel Group Minority 000 0000 000000 0
WBC Ventures Accelerator/Incubator 000 0000 000000 0
To view Aquilon Pharma’s complete investors history, request access »